|Period||Company||Revenue||Profit Before Tax||Tax||Profit After Tax||Earning Per Share|
|2020 9M||Union Diagnostic Clinical Services||1,018.45||-553.47||-5.09||-558.57||-0.16|
|2020 9M||Pharma Deko Plc||355.11||-161.29||0.00||-161.29||-74.00|
|2020 9M||Morison Industries Plc||98.23||-46.51||0.00||-46.51||-0.05|
|2020 9M||May & Baker Nigeria Plc||6,438.07||1,002.55||-320.82||681.73||39.52|
|2020 9M||Glaxo SmithKline Consumer Nig. Plc||16,447.21||638.71||-204.39||434.32||36.00|
|2020 9M||FIDSON HEALTHCARE Plc||13,647.46||1,435.86||-459.48||976.39||0.00|
|2020 9M||Ekocorp Plc||743.65||-230.22||0.00||-230.22||-46.20|
In the second quarter of 2020, Morison Industries Plc grew its revenue by 53% from N82.79 billion in the second quarter of 2019 to N87.31 billion in the period under review. In this period, Fidson Healthcare Plc (11%) and May & Baker Plc (5%) also grew thier revenue. Ekocorp Plc recorded the highest decrease in revenue (65% - from N659 million to N228 milliion), while Pharma Deko Plc recorded a 49% decrease in revenue (from N274 million to N139 million).
Meanwhile, Fidson Healthcare Plc recorded the highest increase in profit after tax, representing 81% increase compared with the previous period. Also, May & Baker recorded increased profit after tax, representing 36% increase compared with the previous period. Although, GlaxoSmithKline Consumer Nig. Plc managed to increase its revenue by 5% in the period under consideration, it recorded a profit after tax of N305 million, representing 18% decrease compared with the N372 million recorded in the second quarter of 2019. Morison Industries Plc (44%), Ekocorp Plc (21%) and Pharma Deko (14%) all recorded decreased profit after tax.
Data Source: Nigerian Stock Exchange
Nairametrics Exclusive Research!